β-catenin Mutations Are Not Involved in Early-stage Hepatocarcinogenesis Induced by Protoporphyrinogen Oxidase Inhibitors in Mice
Authors:
Open Access
- 5 June 2017
- journal article
- research article
- Published by SAGE Publications in Toxicologic Pathology
- Vol. 45 (4) , 493-505
Abstract
We previously reported the contribution of constitutive androstane receptor (CAR) in cytotoxicity-related hepatocarcinogenesis induced by oxadiazon (OX) or acifluorfen (ACI), two pesticides categorized as protoporphyrinogen oxidase (PROTOX) inhibitors. The molecular characteristics of preneoplastic and neoplastic lesions induced by OX and ACI were immunohistochemically compared to those by phenobarbital (PB), a typical CAR activator, in wild-type (WT) and CAR knockout (CARKO) mice after diethylnitrosamine initiation. We focused on changes in β-catenin and its transcriptional product glutamine synthetase (GS). In PB-promoted foci and adenomas, nuclear accumulation of mutated β-catenin was increased with high frequency. PB treatment also increased the multiplicity and area of GS-positive foci and adenomas in WT mice. No foci and adenomas showed nuclear accumulation of β-catenin and expression of GS in CARKO mice, similar to both genotypes of mice treated with OX and ACI. Interestingly, hepatocellular carcinoma induced in ACI-treated WT mice showed nuclear accumulation of β-catenin and was positive for GS. Our results indicated that β-catenin mutations were not involved in early-stage hepatocarcinogenesis induced by PROTOX inhibitors in mice, although activation of β-catenin and CAR is important in PB-induced tumorigenesis. The significant differences in molecular profiles suggested involvements of multiple mode of actions for hepatocarcinogenesis induced by PROTOX inhibitors.Keywords
This publication has 22 references indexed in Scilit:
- Beta-catenin signaling, liver regeneration and hepatocellular cancer: Sorting the good from the badSeminars in Cancer Biology, 2011
- Proliferative and Nonproliferative Lesions of the Rat and Mouse Hepatobiliary SystemToxicologic Pathology, 2010
- PERK promotes cancer cell proliferation and tumor growth by limiting oxidative DNA damageOncogene, 2010
- Wnt/β-Catenin Signaling Activates and Determines Hepatic Zonal Expression of Glutathione S-Transferases in Mouse LiverToxicological Sciences, 2010
- Hepatocarcinogenesis in mice with a conditional knockout of the hepatocyte growth factor receptor c‐MetInternational Journal of Cancer, 2009
- Differential selection for B-raf and Ha-ras mutated liver tumors in mice with high and low susceptibility to hepatocarcinogenesisMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2008
- B-Raf and Ha-ras mutations in chemically induced mouse liver tumorsOncogene, 2004
- Selective pressure during tumor promotion by phenobarbital leads to clonal outgrowth of β-catenin-mutated mouse liver tumorsOncogene, 2001
- Mutations in the ras proto-oncogene: clues to etiology and molecular pathogenesis of mouse liver tumorsToxicology, 1995
- Toxicology updateJournal of Applied Toxicology, 1994